Date: 2016-04-05
Type of information: Collaboration agreement
Compound: 3DEXPERIENCE platform
Company: Dassault Systèmes (France) Ipsen (France)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On April 5, 2016, Dassault Systèmes and Ipsen announced their collaboration for innovative programs using the
3DEXPERIENCE platform. Ipsen has selected the “Designed to Cure” industry solution experience to accelerate its R&D transformation and discovery of new therapeutic solutions. The platform offers data integration, modeling and simulation capabilities to gain a more comprehensive view of the dysregulations linked to diseases as well as improves and shortens the identification of higher quality drug candidates. The project also aims to optimize the R&D processes of Ipsen’s multi-disciplinary teams located in the heart of the leading biotechnological and life sciences hubs in France, the U.K. and the U.S., as well as those of its worldwide network of drug development partners including worldclass scientists, Biotechs, clinical research organizations, and other stakeholders.
Financial terms:
Latest news:
